Core Viewpoint - The board of directors of Guangdong Songfa Ceramics Co., Ltd. held its first meeting of the seventh session, where several key resolutions were passed, including the election of the chairman and various committee members, as well as the appointment of senior management positions. Group 1: Board Elections and Appointments - Chen Jianhua was elected as the chairman of the board for the seventh session, with unanimous support (9 votes in favor) [1] - The members and chairpersons of the specialized committees were elected, including: - Strategic and Sustainable Development Committee: Chen Jianhua (Chair), Chen Hanlun, Zhou Bo [2] - Audit Committee: Xu Haoran (Chair), Li Zhiwen, Wang Yue [2] - Nomination Committee: Li Zhiwen (Chair), Xu Haoran, Shi Yugao [2] - Compensation and Assessment Committee: Zhou Bo (Chair), Xu Haoran, Wang Xiaohai [2] Group 2: Senior Management Appointments - Chen Hanlun was appointed as the general manager, with unanimous support (9 votes in favor) [2] - Wang Xiaohai, Shi Yugao, Zhang Enguo, Su Tianfeng, Wang Lei, and Xu Huimin were appointed as deputy general managers, with unanimous support (9 votes in favor) [2] - Xu Huimin was appointed as the board secretary, with unanimous support (9 votes in favor) [3] - Feng Xianyong was appointed as the financial director, with unanimous support (9 votes in favor) [3] Group 3: Governance and Financial Management - The board approved the formulation, revision, and abolition of certain governance systems to enhance the company's operational standards and governance structure, with unanimous support (9 votes in favor) [4] - The company will use up to RMB 500 million of temporarily idle raised funds for cash management, with a validity period of 12 months, ensuring the safety of the raised funds [4][5] - The company approved the use of RMB 3.5 billion of raised funds to replace self-raised funds previously invested in projects, with the replacement occurring within six months of the funds being received [5]

Group 1 - The board of directors of China Shipbuilding (Handan) Special Gas Co., Ltd. held its sixth meeting of the second session on August 18, 2025, with all nine directors present, confirming the legality and validity of the meeting [1] - The board approved the special report on the storage and actual use of raised funds for the first half of 2025, in compliance with relevant regulations and company management methods [2][3] - The board also approved a risk assessment report regarding China Ship Finance Co., Ltd., with all relevant votes in favor [2][3] Group 2 - The board agreed to use temporarily idle raised funds and self-owned funds for cash management, with a maximum amount not exceeding a specified limit [2][3] - The board approved the 2025 half-year report and its summary, which were prepared according to regulatory requirements [3][4] - A semi-annual evaluation report for the "Quality Improvement and Efficiency Enhancement" action plan for 2025 was also approved by the board [4] Group 3 - The company plans to hold its third extraordinary general meeting of shareholders on September 10, 2025, using a combination of on-site and online voting methods [5]

Core Points - The company held its 16th meeting of the second supervisory board on August 21, 2025, where all three supervisors attended, confirming the meeting's legality and effectiveness [1] - The supervisory board unanimously agreed that the procedures for preparing and reviewing the 2025 semi-annual report complied with relevant laws and regulations, and the report accurately reflects the company's actual situation [1][2] - The board confirmed that the management and use of raised funds complied with regulatory requirements, with no violations noted [2] - The supervisory board approved the use of idle raised funds for cash management, which is expected to enhance fund utilization efficiency and generate investment returns [2][3] - The board agreed that the provision for asset impairment was in line with accounting standards and accurately reflects the company's financial status [3] - The decision to use self-owned assets as collateral for bank credit applications was deemed beneficial for the company's development and compliant with relevant regulations [3] - The proposals will be submitted for review at the company's first extraordinary general meeting of 2025 [4]

Fundraising Overview - The company raised a total of RMB 8,864,751,000.00 through the issuance of convertible bonds, with a net amount of RMB 8,816,100,720.15 after deducting issuance costs [1][4] - As of June 30, 2025, the company had a remaining balance of RMB 101,967,265.80 in its special account for the raised funds [1][3] Fund Utilization - The total amount utilized from the raised funds was RMB 16,140.43 million, with RMB 5,547,451,349.66 allocated to investment projects and RMB 1,302,391,145.98 for replacing pre-invested amounts [2][4] - The company temporarily used RMB 1,900,000,000.00 of idle funds to supplement working capital, which is limited to business expansion and daily operations [2][3] Fund Management - The company established a special account for the management of raised funds, ensuring all funds are stored in a dedicated bank account [1][4] - As of June 30, 2025, the company had no idle funds used for cash management or any super-raised funds permanently supplementing working capital or repaying bank loans [3][4] Project Status - The company’s investment project, the annual production of 35GW monocrystalline silicon project, has experienced delays, with the second phase's expected operational date pushed to June 2026 [6][7] - The first phase of the project has been put into production, but the expected benefits have not been realized due to declining silicon prices [7]

天合光能股份有限公司 募集资金管理制度 第一章 总 则 第一条 为规范天合光能股份有限公司（以下简称"公司"）募集资金的使 用与管理，提高募集资金的使用效率，防范资金使用风险，确保资金使用安全， 保护投资者的利益，根据《中华人民共和国公司法》《中华人民共和国证券法》 《监管规则适用指引——发行类第7号》《上市公司募集资金监管规则》《上海 证券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指 引第1号——规范运作》等法律法规、法规、规范性文件，以及《天合光能股份 有限公司章程》的要求，结合公司实际情况，制定本制度。 第二条 本制度所称募集资金系指公司通过向不特定对象发行证券（包括首 次公开发行股票、配股、增发、发行可转换公司债券、发行分离交易的可转换公 司债券等）以及向特定对象发行证券募集的资金，但不包括公司实施股权激励计 划募集的资金。 第三条 公司董事会应当负责建立健全公司募集资金存储、管理和使用的内 部控制制度，并确保该制度的有效实施，该等制度应当对募集资金专户存储、使 用、变更、监督和责任追究等内容进行明确规定。 募集资金投资项目（以下简称"募投项目"）通过公司的子公司或公司控制 的其 ...

Fundraising Overview - The company raised a total of RMB 526,520,754.72 from the issuance of 60 million shares at a price of RMB 8.7753 per share, after deducting issuance costs of RMB 22,181,859.65, resulting in a net amount of RMB 50,433.89 million [1][2] - As of June 30, 2025, the company has utilized RMB 39,673.93 million of the raised funds, with a remaining balance of RMB 13,756.31 million [1][2] Fund Management - The company has established a fundraising management system to ensure proper use and management of the raised funds, with three special accounts opened at various banks [1][2] - The total balance in the special accounts as of June 30, 2025, is RMB 137,563,094.71 [2] Fund Utilization - The company has not used idle funds for temporary working capital and has not made any changes to the fundraising projects during the reporting period [2][3] - The company has approved the use of idle funds for cash management, with a maximum of RMB 200 million allocated for this purpose [2] Project Status - The company has reported that the investment projects are progressing, with specific projects such as the intelligent gas-insulated switchgear and technology research center construction showing varying levels of completion [3] - The completion date for certain projects has been extended to October 2025 to optimize resource allocation and enhance fundraising efficiency [3]

Key Points - The report details the fundraising and usage of funds by Shanghai Aopumai Biotechnology Co., Ltd. for the first half of 2025, ensuring compliance with relevant regulations [1][2] - The total amount raised from the initial public offering (IPO) was approximately RMB 1.644 billion, with a net amount of RMB 1.637 billion after deducting issuance costs [1] - As of June 30, 2025, the company had spent RMB 318.4048 million on fundraising projects and had a remaining balance of RMB 151.2954 million in the fundraising account [1][2] Fundraising Overview - The actual amount raised was RMB 1,643,705,576.40, with a net amount of RMB 1,637,000,000 after fees [1] - The company utilized RMB 318.4048 million for project expenditures and invested RMB 546 million in financial products [1] - The company generated a net interest income of RMB 48.6477 million from the funds [1] Fund Usage and Management - The company has established a dedicated account for fundraising, with a balance of RMB 151.2954 million as of June 30, 2025 [1][2] - The company has permanently supplemented working capital with surplus funds amounting to RMB 192.8819 million [1] - The company has implemented a cash management strategy for idle funds, allowing for investment in high-security, liquid financial products [2][3] Project Status - The company has completed the fundraising projects "Aopumai CDMO Biopharmaceutical Commercialization Production Platform" and "Aopumai Cell Culture R&D Center," with surplus funds permanently allocated to working capital [1][2] - There were no changes to the fundraising project usage during the reporting period [4] Compliance and Reporting - The company has adhered to the regulations regarding fundraising management and disclosure, ensuring timely and accurate reporting of fundraising activities [4] - There were no violations in the management and disclosure of fundraising [4]

第三版 制度编号 BL〔01BA13〕号 通商密 有效版次 普 发布日期 上海贝岭股份有限公司 募集资金管理制度 （2025 年 8 月 21 日公司第九届董事会第二十次会议审议稿） 第一章 总则 第一条 为了加强对上海贝岭股份有限公司（以下简称"公司"）募集资金的管理， 提高募集资金使用效益，根据《中华人民共和国证券法》（以下简称《证券法》）《上 市公司证券发行注册管理办法》《上市公司募集资金监管规则》《上海证券交易所股票 上市规则》《上海证券交易所上市公司自律监管指引第 1 号——规范运作》等法律、法 规和规范性文件以及《上海贝岭股份有限公司章程》（以下简称《公司章程》）的规定， 制定本制度。 第二条 本制度适用于公司通过发行股票或者其他具有股权性质的证券，向投资者 募集并用于特定用途的资金，但不包括公司为实施股权激励计划募集的资金。 超募资金是指实际募集资金净额超过计划募集资金金额的部分。 第三条 公司募集资金应当专款专用。公司使用募集资金应当符合国家产业政策和 相关法律法规，践行可持续发展理念，履行社会责任，原则上应当用于主营业务，有利 于增强公司竞争能力和创新能力。 第四条 公司建立并完善募集资金存 ...

Core Viewpoint - The report details the fundraising and usage status of Shanghai Daming City Enterprise Co., Ltd., highlighting the termination of a specific investment project and the allocation of surplus funds to working capital [1][2][9]. Fundraising Overview - The company raised a total of RMB 2,959,970,000 after deducting issuance costs of RMB 40,030,000, with the funds received on September 24, 2014 [1][2]. - The surplus funds amounting to RMB 222,296,700 were permanently allocated to working capital after the termination of the Mingcheng Yongtai Eastern Hot Spring Tourism New District Phase I project [2][9]. Fund Management - The company has established a fundraising management system in compliance with relevant laws and regulations, ensuring that funds are stored in dedicated accounts and used strictly for approved projects [3][4]. - As of June 30, 2025, the special accounts for the raised funds have been either canceled or converted to general accounts [4][9]. Fund Usage - The company has utilized RMB 273,770,000 from the raised funds, with no changes in the investment projects [10]. - The company has temporarily supplemented working capital with idle funds, ensuring that these actions do not affect the construction of fundraising projects [6][11]. Project Termination and Surplus Funds - The investment project associated with the 2013 non-public offering has been terminated, and the remaining funds have been redirected to working capital [9][12]. - The total surplus funds allocated to working capital amount to RMB 222,296,700, with no other uses reported [11][12].

Summary of Key Points Core Viewpoint - The report outlines the fundraising activities and the management of raised funds by Zhuzhou Times New Material Technology Co., Ltd. for the first half of 2025, indicating that all raised funds have been received and are being managed according to regulatory requirements [2][5]. Fundraising Basic Situation - The company raised a total of RMB 1,289,370,062.47 through a specific stock issuance at a price of RMB 12.18 per share, with all funds received by June 26, 2025 [2][3]. - As of June 30, 2025, the balance of the fundraising account was RMB 1,290,899,998.65, with no funds utilized yet [3][4]. Fund Management Situation - The company has established a fundraising management system in compliance with relevant regulations to ensure efficient use and management of the funds [3][4]. - A tripartite/four-party supervision agreement for the fundraising account was signed with various banks and the sponsor institution on July 9, 2025 [3][4]. Actual Use of Fundraising - No funds have been used for any projects or operational expenses as of the reporting date [5][6]. - There were no instances of using idle funds for temporary working capital or cash management during the reporting period [5][6]. Changes in Fundraising Projects - There were no changes to the fundraising projects or any external transfers or replacements of projects during the reporting period [6][7]. Issues in Fund Use and Disclosure - The company has adhered strictly to legal and regulatory requirements in managing and disclosing the use of raised funds, with no violations reported [6][8].